KEGG   DRUG: Zidovudine and lamivudine
Entry
D07507            Mixture   Drug                                   
Name
Zidovudine and lamivudine;
Combivir (TN);
Lamivudine zidovudine (TN)
Product
  Generic
Component
Zidovudine [DR:D00413], Lamivudine [DR:D00353]
Class
Antiviral
 DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
 DG03107  Anti-HIV agent
Remark
Therapeutic category: 6250
ATC code: J05AR01
Product: D07507<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 reverse transcriptase [KO:K24802]
  Pathway
ko03230  Viral genome structure
ko03240  Viral replication
ko03250  Viral life cycle - HIV-1
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR01 Zidovudine and lamivudine
      D07507  Zidovudine and lamivudine <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Lamivudine/ Zidovudine
    D07507  Zidovudine and lamivudine
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D07507  Zidovudine and lamivudine
Drug groups [BR:br08330]
 Antiviral
  DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
   D07507  Zidovudine and lamivudine
  DG03107  Anti-HIV agent
   D07507  Zidovudine and lamivudine
Drug classes [BR:br08332]
 Antiviral
  DG03107  Anti-HIV agent
   D07507  Zidovudine and lamivudine
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D07507  Zidovudine and lamivudine <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D07507
Other DBs
PubChem: 51091831
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system